|
[1]
|
Henter, J.I., Horne, A., Arico, M., et al. (2007) HLH-2004: Diagnostic and Therapeutic Guidelines for Hemophagocytic Lymphohistiocytosis. Pediatric Blood & Cancer, 48, 124-131. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Score. http://saintantoine.aphp.fr/score
|
|
[3]
|
Ayusawa, M., Sonobe, T., Uemura, S., et al. (2005) Revision of Diagnostic Guidelines for Kawasaki Disease (the 5th Revised Edition). Pediatrics International, 47, 232-234. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
McCrindle, B.W., Rowley, A.H., Newburger, J.W., et al. (2017) Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Pro-fessionals from the American Heart Association. Circulation, 135, e927-e999.
|
|
[5]
|
林瑶, 李晓惠, 石琳, 杜军保. 2017年版《川崎病的诊断、治疗及远期管理——美国心脏协会对医疗专业人员的科学声明》解读[J]. 中国实用儿科杂志, 2017, 32(9): 641-648.
|
|
[6]
|
噬血细胞综合征中国专家联盟, 中华医学会儿科学分会血液学组. 噬血细胞综合征诊治中国专家共识[J]. 中华医学杂志, 2018, 98(2): 91-95.
|
|
[7]
|
Doğan, V., Karaaslan, E., et al. (2016) Hemophagocytosis in the Acute Phase of Fatal Kawasaki Disease in a 4 Month-Old Girl. Balkan Medical Journal, 33, 470-472. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Chen, Y., Shang, S., Zhang, C., et al. (2010) He-mophagocytic Lymphohistiocytosis at Initiation of Kawasaki Disease and Their Differential Diagnosis. Pediatric Hema-tology and Oncology, 27, 244-249. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Choi, J.E., Kwak, Y., et al. (2018) Differentiation between In-complete Kawasaki Disease and Secondary Hemophagocytic Lymphohistiocytosis Following Kawasaki Disease Using N-Terminal Pro-Brain Natriuretic Peptide. Korean Journal of Pediatrics, 61, 167-173. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Nasir, A., Al Tatari, H. and Hamdan, M.A. (2012) Very High Se-rum Ferritin Levels in Three Newborns with Kawasaki-Like Illness. Paediatrics & Child Health, 17, 201-204. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Lerkvaleekul, B., Vilaiyuk, S., et al. (2018) Macrophage Activation Syn-drome: Early Diagnosis Is Key. Open Access Rheumatology: Research and Reviews, 10, 117-128. [Google Scholar] [CrossRef]
|
|
[12]
|
Vilaiyuk, S., Sirachainan, N., et al. (2013) Recurrent Macrophage Activation Syndrome as the Primary Manifestation in Systemic Lupus Erythematosus and the Benefit of Serial Ferritin Measurements: A Case-Based Review. Clinical Rheumatology, 32, 899-904. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Kostik, M.M., Dubko, M.F., Masalova, V.V., et al. (2015) Identi-fication of the Best Cutoff Points and Clinical Signs Specific for Early Recognition of Macrophage Activation Syndrome in Active Systemic Juvenile Idiopathic Arthritis. Seminars in Arthritis and Rheumatism, 44, 417-422. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Schulert, G.S., Grom, A.A., et al. (2015) Pathogenesis of Macrophage Activation Syndrome and Potential for Cytokine-Directed Therapies. Annual Review of Medicine, 66, 145-159. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Put, K., Avau, A., Brisse, E., et al. (2015) Cytokines in Systemic Juvenile Idiopathic Arthritis and Haemophagocytic Lymphohistiocytosis: Tipping the Balance between Interleu-kin-18 and Interferon-γ. Rheumatology, 54, 1507-1517. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Lerkvaleekul, B. and Vilaiyuk, S. (2018) Macrophage Activation Syndrome: Early Diagnosis Is Key. Open Access Rheumatology, 10, 117-128. [Google Scholar] [CrossRef]
|
|
[17]
|
Wang, W., Gong, F., Zhu, W., Fu, S., et al. (2015) Macrophage Activation Syndrome in Kawasaki Disease: More Common than We Thought? Seminars in Arthritis and Rheumatism, 44, 405-410. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Latino, G.A., Manlhiot, C., Yeung, R.S., et al. (2010) Mac-rophageactivation Syndrome in the Acute Phase of Kawasaki Disease. Journal of Pediatric Hematology/Oncology, 32, 527-531. [Google Scholar] [CrossRef]
|
|
[19]
|
郭莉, 卢美萍, 等. 巨噬细胞活化综合征的临床和实验室特征分析[J]. 中国当代儿科杂志, 2017, 19(2): 188.
|
|
[20]
|
Kang, H.R., Kwon, Y.H., Yoo, E.S., et al. (2013) Clinical Characteristics of Hemophagocytic Lymphohistiocytosis Following Kawasaki Disease: Differentiation from Re-current Kawasaki Disease. Blood Research, 48, 254-257. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Shafferman, et al. (2014) High Dose Anakinra for Treatment of Se-vere Neonatal Kawasaki Disease: A Case Report. Pediatric Rheumatology, 12, 26. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Servel, A.C., Vincenti, M., Darras, J.P., et al. (2012) Intravenous Immunoglobulin-Resistant Kawasaki Disease with Hemophagocytosis. Archives de Pédiatrie, 19, 741-744. [Google Scholar] [CrossRef] [PubMed]
|